| ¿µ¹® | Addison disease | ÇÑ±Û | ¾Öµð½¼º´ |
|---|---|---|---|
| ¼³¸í | ºÎ½Å°ÑÁúÀÇ º´ÅÍ·Î ÀÎÇÏ¿© ºÎ½Å°ÑÁúÀÇ È£¸£¸óÀÌ ³ª¿ÀÁö ¸øÇؼ »ý±â´Â º´. ¿ì¸®³ª¶ó¿¡¼ °¡Àå ¸¹Àº ¿øÀÎÀº °áÇÙÀÌ´Ù. ¾Öµð½¼º´¿¡¼´Â ºÎ½Å°ÑÁúÀÇ ÆÄ±«¿¡ ÀÇÇØ¼ ºÎ½Å°ÑÁú¿¡¼ ³ª¿À´Â È£¸£¸óÀÌ ¾ø¾îÁö¹Ç·Î ÄáÆÏ¿¡¼ ¹°ÀÇ Èí¼öÀå¾Ö·Î ÀÎÇØ Å»¼ö»óŰ¡ Áö¼ÓµÇ¸ç, ½ºÆ®·¹½º È£¸£¸óÀÇ °áÇÌ¿¡ ÀÇÇØ¼ ¸¸¼ºÇÇ·Î, üÁß°¨¼Ò µîÀÇ Áõ»óÀÌ »ý±â¸ç, ³úÇϼöü¿¡¼ ºÎ½Å°ÑÁúÀÇ ºÐºñ¸¦ ³ôÀÌ´Â ºÎ½Å°ÑÁúÀÚ±ØÈ£¸£¸óÀÇ °ú´Ù ºÐºñ·Î ÀÎÇØ¼ °°ÀÌ ºÐºñµÇ´Â ¸á¶ó´ÑÀÚ±ØÈ£¸£¸ó¿¡ ÀÇÇØ ¾ó±¼°ú ÀÔ¼ú¿¡ °úµµÇÑ »ö¼ÒÀÇ Ä§ÂøÀ» º¼ ¼ö ÀÖ´Ù. |
||
| ¿µ¹® | planes of body | ÇÑ±Û | ÀÎüÀÇ ¸é |
|---|---|---|---|
| ¼³¸í | ÀÎü¸¦ ¿©·¯ °³·Î ³ª´©´Â ¸éÀÌ Àִµ¥, Å©°Ô ½Ã»ó¸é(sagittal plane), °ü»ó¸é(coronal plane), ¼öÆò¸é(horizontal plane)À¸·Î ³ª´ ¼ö ÀÖ´Ù. ½Ã»ó¸éÀº ÀÎü¸¦ Á¿ì·Î, °ü»ó¸éÀº ¾ÕµÚ·Î, ¼öÆò¸éÀº À§¾Æ·¡·Î °¡¸£´Â ¸éÀÌ´Ù. |
||
| CR | calculation rate; calculus removed; calorie-restricted; cardiac rehabilitation; cardiac resuscitatio... |
|---|---|
| CS | calf serum; campomelic syndrome; carcinoid syndrome; cardiogenic shock; caries-susceptible; carotid ... |
| HSM Syndrome | juvenile-familial Endocrinopathy Hypoparathyroidism Addison's Disease Menillansis |
| HAM | hearing aid microphone; helical axis in motion; human albumin microsphere; human alveolar macrophage... |
| MEDAC | multiple endocrine deficiency, Addison's disease, and candidiasis [syndrome] |
| ACTG | AIDS Clinical Trials Group |
|---|---|
| ASCO | American Society of Clinical Oncology |
| CAI | Clinical Activity Index |
| CAL | Clinical Attachment Level |
| CCR | Clinical Complete Response |
| Addison's clinical planes | A series of plane's used as landmarks in thoracoabdominal topography; the trunk is divided vertically by a median plane from the upper border of the manubrium of the sternum to the pubic symphysis, by a lateral plane drawn vertically on either side through a point half way between the anterior superior iliac spine and the median plane at the interspinal plane, and by an interspinal plane passing vertically through the anterior superior iliac spine on either side; transversely the trunk is divided by a transthoracic plane passing across the thorax 3.2 cm above the lower border of the body of the sternum, by a transpyloric plane midway between the jugular notch of the sternum and the pubic symphysis, corresponding to the disc between the first and second lumbar vertebrae, and by an intertubercular plane passing through the iliac tubercles and cutting usually the fifth lumbar vertebra; the plane's formed on these lines, and also on transverse plane's cutting the upper edge of the manubrium and the upper edge of the pubic symphysis, constitute the clinical plane's of Addison. (05 Mar 2000) |
|---|
| planes of reference | Plane's which act as a guide to the location of other plane's. (05 Mar 2000) |
|---|---|
| conjugate planes/points | <microscopy> Planes (or points) that are in focus relative to each other. In a microscope adjusted for Koehler illumination, there are two sets of conjugate planes: the aperture planes and the field planes. See: field planes, Koehler illumination (05 Aug 1998) |
| field planes | <microscopy> The set of planes in a microscope adjusted for Kohler illumination that are conjugate with the focused specimen. They include the plane of the specimen, the field diaphragm, the intermediate image plane, and the image on the retina, photographic emulsion, or the faceplate of the video pickup device. (05 Aug 1998) |
| Addison-Biermer disease | <haematology> A form of anaemia (low red blood cell counts) that results when the bone marrow fails to produce adequate numbers of red blood cells due to a deficiency in vitamin B12. Intrinsic factor, necessary for normal B12 absorption, may be the underlying cause for B12 deficiency if is not produced in the gastric glands (in the stomach). Origin: Gr. Haima = blood (27 Sep 1997) |
| Addison, Christopher | <person> English anatomist, 1869-1951. See: Addison's clinical planes. (05 Mar 2000) |
| Addison's anaemia | <haematology> A form of anaemia (low red blood cell counts) that results when the bone marrow fails to produce adequate numbers of red blood cells due to a deficiency in vitamin B12. Intrinsic factor, necessary for normal B12 absorption, may be the underlying cause for B12 deficiency if is not produced in the gastric glands (in the stomach). Origin: Gr. Haima = blood (27 Sep 1997) |
| Addison's disease | <endocrinology> A rare endocrine disease that results from the underproduction of aldosterone and cortisol (hormones) by the adrenal glands. Symptoms include weakness, low blood pressure, anaemia, low blood sugar and electrolyte abnormalities. (27 Sep 1997) |
| Addison, Thomas | <person> English physician, 1793-1860. See: Addison's anaemia, Addison's disease, addisonian anaemia, addisonian crisis, Addison-Biermer disease. (05 Mar 2000) |
| disease, addison's | Long-term underfunction of the outer portion of the adrenal gland. In medical terms, chronic insufficiency of the adrenal cortex. This may be due to a number of different insults to the adrenal including physical trauma, haemorrhage, and tuberculosis of the adrenal, and destruction of the cells in the pituitary gland that secrete ACTH (adrenocorticotropic hormone) which normally drives the adrenal. Addison's disease is characterised by bronzing of the skin, anaemia, weakness, and low blood pressure. The U.S. President J.F. Kennedy is said to have had Addison's disease. Named after the British physician Thomas Addison (1793-1860). (12 Dec 1998) |
| pathology, clinical | A subspecialty of pathology which deals with the laboratory analysis of specimens of human blood and other fluids. (12 Dec 1998) |
| chemistry, clinical | The specialty of analytical chemistry applied to assays of physiologically important substances found in blood, urine, tissues, and other biological fluids for the purpose of aiding the physician in making a diagnosis or following therapy. (12 Dec 1998) |
| pharmacology, clinical | The branch of pharmacology that deals directly with the effectiveness and safety of drugs in humans. (12 Dec 1998) |
| phase I clinical trial | <pharmacology> The earliest stage clinical trial for studying an experimental drug in humans. Phase I trials are generally comparatively small and are used to determine toxicity and maximum dose. They provide an initial evaluation of a drug's safety and pharmacokinetics-how the drug is absorbed, what tissues it reaches and how long it takes to leave the body. Such studies also usually test various doses of the drug (dose-ranging) to obtain an indication of the appropriate dose to use in later studies. The patients in these trials usually have advanced disease and have already received best available chemotherapy, therefore, seeing a repose is significant partially because this means there is a lack of cross-resistance between two anti-cancer drugs. (31 Dec 1997) |
| phase II clinical trial | <pharmacology> Usually focus on the activity of the new product as a single agent in a noncomparative, open study. (31 Dec 1997) |
| phase III clinical trial | <pharmacology> An advanced stage clinical trial that should conclusively show how well a drug works as compared to other treatments. Phase III trials are large, frequently multi-institution tests. They generally compare the relative value of the new drug compared with the current standard treatment and measure whether a new drug extends survival or otherwise improves the health of patients on treatment (clinical improvement) rather than just provide surrogate marker data. These studies generally last longer and are larger than phase II trials. (31 Dec 1997) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|